IP Library Assignment 051422/0763
Patent Assignment
Reel/Frame 051422/0763

Assignment of Assignor's Interest

Recorded: 2020-01-06 Pages: 3
Assignor
SYNGENE INTERNATIONAL LIMITED
Executed: 2019-12-17
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property (1)
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
Application: 62/934,167 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 6, 2020
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051422/0618 →
Assignment of Assignor's Interest Jan 6, 2020
From: SEENISAMY, JEYAPRAKASHNARAYANAN
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 051422/0667 →
Merger Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053173/0089 →
Change of Name Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0734 →
Change of Name Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059810/0102 →